Navigation Links
Gene therapy study shows safety and statistically significant improvement in Parkinson's disease

time of surgery, while prior studies of AAV-mediated gene therapy show that gene expression gradually increases to a maximal level over a period of weeks.

“We are very encouraged by the results of this trial and its publication in such a prestigious journal,” said John Mordock, Neurologix President and Chief Executive Officer. “Since the inception of the company, we have been a leader in developing gene therapy for neurological disease, and we feel that rigorous peer-review and publication of the results from this first-ever trial is an important milestone for this entire field. These promising observations certainly warrant further, more definitive testing of Neurologix’s technology, and we anticipate beginning a larger Phase 2 study in Parkinson’s disease later this year. Moreover, the results also provide a solid foundation for the development of our other therapeutic programs, including epilepsy where we plan to initiate a Phase 1 gene therapy study this year.”

Study Design

The study included 12 patients with advanced Parkinson’s disease, with four patients in each of three dose-escalating cohorts. All procedures were performed under local anesthesia and all 12 patients were discharged from the hospital within 48 hours of the procedure. At one year, all 12 patients as a group demonstrated a clinical improvement of 25% in the Unified Parkinson’s disease Rating Scale (UPDRS) compared to baseline (p<0.005). Nine of the 12 patients showed an average of 37% and five of these patients had substantial improvement of between 40% and 65%. Clinical improvement also correlated well to metabolic changes in glucose utilization as measured by PET scan. The PET scan data revealed a significant improvement (p<0.001) in brain metabolism on the treated side of the brain compared to the untreated side. No adverse events related to the gene therapy procedure were reported throughout the duration of the 12-month study, or in the subsequent two
'"/>

Source:JKureczka@comcast.net


Page: 1 2 3 4

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
8. New therapy for HIV/AIDS eliminates needles and excessive toxicity
9. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
10. Gene therapy for Parkinsons disease moves forward in animals
11. Pulsating ultrasound enhances gene therapy for tumors

Post Your Comments:
(Date:11/4/2009)..., Calif., Nov. 4 GenVault Corporat...ody, M.D., Ph.D., has joined its Board of Director... of the Salk Institute, is an acclaimed physician-... the Salk Institute, Dr. Brody served as president...of the National Academy of Engineering and the Ins...
(Date:11/3/2009)...ark may be the ultimate loner of the ocean, cruisi...am of researchers has discovered that the sharks h...ion that over tens of thousands of years the white...arated themselves into a population genetically di...ite sharks are a large, highly mobile species," sa...
(Date:11/3/2009)...EST LAFAYETTE, Ind. - Chief executives in 35 of th... 129 times their "ideal salaries" in 2008, accordi...by a Purdue University researcher to determine fai...economic and corporate governance issues of the da... said Venkat Venkatasubramanian, a professor of ch...
Breaking Biology News(10 mins):Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4New Certification Commission for Healthcare Interpreters Opens Doors to Improve Provider Patient Communication 26 Quality Medical Care 57223 1New Certification Commission for Healthcare Interpreters Opens Doors to Improve Provider Patient Communication 26 Quality Medical Care 57223 2New Certification Commission for Healthcare Interpreters Opens Doors to Improve Provider Patient Communication 26 Quality Medical Care 57223 3Gene Switch May Help Drive Excess Fluid in Lungs 57218 1Comprehensive cardiac CT scan may give clearer picture of significant heart disease 57214 1Comprehensive cardiac CT scan may give clearer picture of significant heart disease 57214 2
...molecular biologists at Cold Spring Harbor Laborat... a gene mutation causes a cellular editing error t...erebellar hypoplasia (PCH). The new findings were... in the journal Nature Structural and Molecular B...ood, PCH is characterized by the slow wasting away...
...USTA, Ga. Researchers may have found why women ha...the amount of salt they eat and excrete - at least... are known to have fewer problems with salt-sensit...afterward their risks are essentially the same as ... the Vascular Biology Center at the Medical Colleg...
... declining mountain caribou populations of Canada,...scientists previously believed, according to a new...s shedding light on the ancient ancestry of the mo...d in the current issue of the journal Molecular E...date Byron Weckworth and his research group descri...
Other Biology News:CSHL scientists clarify editing error underlying genetic neurodegenerative disease 2CSHL scientists clarify editing error underlying genetic neurodegenerative disease 3CSHL scientists clarify editing error underlying genetic neurodegenerative disease 4Researchers may have found why women have an edge on salt-sensitive hypertension 2Mountain caribou's ancient ancestry revealed 2
(Date:11/5/2009)... 5 Transgenomic, Inc. (O... results for the quarter ended September 30, 2009....the tables that follow. ,, Third Quarter 2009 ... or $0.01 per share for the third quarter of 2009 ... share for the third quarter of 2008. ,, Net s...
(Date:11/5/2009)...Nov. 5 WaferGen Biosyste...eloper of state-of-the-art genetic analysis system...as joined the company,s Scientific Advisory Board....mercializing novel molecular diagnostics for cance...elopment of computational biology systems for seve...
(Date:11/5/2009)... Brooke Sanders brings a new look to Pro Repro ...ber 5, 2009 -- Professional Reprographics, Orange ...ny is pleased to present Brooke Sanders to the com...R specialist. The addition of Brooke to the compan...n Professional Reprographics., , ,Brooke brings wi...
(Date:11/4/2009)...LE, Md., Nov. 4 Zyngenia, Inc., a ...next-generation antibody drug development, today a... A funding from New Enterprise Associates (NEA), o...he capital will be used to create novel, multi-spe...more biological targets with a single agent. The c...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
...ceive recombinant Bovine Somatotropin (rbST) make ...ressure and substantially reducing environmental i...be published in the Proceedings of the National A... milk uses large quantities of land, energy and fe...erican farms has been in agricultural use for nea...
...parta),the maker of TrackWise(R) and the market le...nt software, today announced that Genzyme, a,world...a Systems to enhance,its quality management progra...ive and Preventive Actions,(CAPA) as well as devia...as,chosen to replace an existing solution and lega...
...pond to NEBIDO Delay, LEXINGTON, Mass., June 30 ...ay announced that it has received,an approvable le...DA) for,NEBIDO(R) related to a New Drug Applicatio...etter, received on June 27, 2008, indicated that t...ble to adequately respond to,certain clinical defi...
Other Biology Technology:Carbon hoofprint: Cows supplemented with rbST reduce agriculture's environmental impact 2Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise 2Indevus Receives Approvable Letter from FDA for NEBIDO(R) 2Indevus Receives Approvable Letter from FDA for NEBIDO(R) 3Indevus Receives Approvable Letter from FDA for NEBIDO(R) 4Indevus Receives Approvable Letter from FDA for NEBIDO(R) 5Indevus Receives Approvable Letter from FDA for NEBIDO(R) 6Indevus Receives Approvable Letter from FDA for NEBIDO(R) 7
PCR Optimizer Kit from Invitrogen
Mouse Anti-Human VEGFB Monoclonal Antibody, Unconjugated, Clone 4H5 from Abnova Corporation
...Infinite 200 series of microplate readers combines...e or absorbance detection in an affordable, easy-t...nce applications. The unique modular design and ad...earchers with a choice of a monochromator (M200) o...
RNA 6000 Nano Chip Kit from Agilent Technologies
Biology Products: